Findings suggest that routine urine drug screening in the ICCU could improve risk stratification, help personalize drug withdrawal support.

A retrospective cohort study found that beta-blocker use is associated with a decreased risk for incident HF in certain SAID populations.

US health officials are proposing a new way to develop and approve custom-made treatments for people with rare and hard-to-treat conditions.

GLP1-RA use may be linked to improved overall survival, but not improved disease-free survival, in breast cancer survivors, researchers report.

HealthDay News — COVID-19 vaccination, especially with a booster dose, is associated with reduced odds of preeclampsia (PE), according to a study published online Feb. 18 in eClinicalMedicine.

A new clinical classification system is presented to define the severity of an acute PE and assist in developing adult treatment strategies.

For individuals with high BP, baduanjin, a traditional Chinese mind-body practice, can lower SBP, with effects sustained for ...

Glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy was associated with reduced Parkinson disease (PD) risk.

Wildfire smoke exposure during pregnancy may increase the risk for autism spectrum disorder (ASD), according to a new study.

Researchers sought to compare pre- and post-ICH blood pressure control across racial, ethnic, and social deprivation groups ...

The US Food and Drug Administration (FDA) is relaxing a long-standing drug approval requirement for common diseases.

FDA approves swallowable Allurion Gastric Balloon for weight loss in adults with obesity who failed prior lifestyle programs.